Takeda Pharmaceutical has formed a 10 billion yen ($87.2 million) drug development company – Scohia Pharma – with two partners, the public-private Innovation Network Corporation of Japan (INCJ) and Medipal Holdings.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
